# Open-Label Phase 1 Study of Aerosolized Amikacin and Fosfomycin in Healthy Volunteers

> **NCT02709265** · PHASE1 · COMPLETED · sponsor: **Cardeas Pharma** · enrollment: 30 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** amikacin/fosfomycin

## Key facts

- **NCT ID:** NCT02709265
- **Lead sponsor:** Cardeas Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2016-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02709265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02709265, "Open-Label Phase 1 Study of Aerosolized Amikacin and Fosfomycin in Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02709265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*